pfizer nyse - Search News

Pfizer, PFE

StockStory.org on MSN · 11h

Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.

The Tokenist · 12h

Pfizer (NYSE: PFE) Reports Better than Expected Q4 Results

Pfizer Inc. (NYSE: PFE) reported a strong performance for the fourth quarter of 2024, with revenues reaching $17.8 billion.

Investing · 12h

Pfizer stock rises after beating Q4 expectations

Pfizer (NYSE: PFE) posted adjusted earnings per share of $0.63 for Q4, exceeding the analyst consensus of $0.48. Revenue came in at $17.8 billion, above expectations of $17.28 billion.

10h

Pfizer Rises on Q4 Earnings Beat, 2025 Outlook Reaffirmed

Pfizer beats Q4 estimates with 24.9% revenue growth, reaffirming 2025 guidance and targeting $4.5 billion in cost savings ...

5h

Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

The Pharma Letter9h

Pfizer beats sales and earnings forecast in 4th-qtr

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...

10hon MSN

Pfizer beats Q4, FY '24 earnings estimates, stock down slightly in premarket trading

Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations ...

11h

Pfizer Q4 Results Beat Market; Confirms FY25 Outlook - Update

Drug major Pfizer Inc. (PFE), while reporting a profit in its fourth quarter, compared to prior year's loss, on Tuesday reaffirmed ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results